GLP-1 drugs: what MassHealth paid

Q: Does a paid prescription mean MassHealth covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Q: Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

Q: What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.

MassHealth shows a published payment figure for 7 of the 8 GLP-1 products this site tracks, in the latest federal quarter. This site has not yet read MassHealth's own coverage rule, so the figures below are a payment history and nothing here tells you what the program will decide next.

By the Covered Weight editorial team · Updated Aug 8, 2026. Research and sourcing by Evan Reid.

What MassHealth’s payment record shows

In 2026Q1, the product MassHealth paid for most often was Zepbound®, at 52,125 prescriptions¹ of the 102,391 to 102,535^{1,7,13,19,25,37,43} across all 8 products, or 51 percent of the published count.

MassHealth itself reimbursed at least $105,628,114 for these products in the quarter, about $1,032 per prescription. Pharmacies were paid $107,711,488 in total, the difference being what other payers covered on the same claims. The costliest per prescription was Mounjaro®, at about $1,049.

Every dollar figure on this page is what pharmacies were paid, before rebates. Manufacturers pay Medicaid programs rebates on these products, the federal file states that its amounts are not reduced by them, and CMS publishes no rebate figure per drug. So what MassHealth finally kept is lower than what is shown here, by an amount this site cannot source.

Paid prescriptions per quarter, MassHealth. The line is what the federal file published and the axis starts at zero. The shaded band is what the file leaves possible above it: each withheld product code stands for between one and ten prescriptions, so a wide band means a heavily suppressed record rather than a busy one. A gap in the line is a quarter the file did not report, never a zero.

What MassHealth paid, product by product

For what each product is approved to treat, the split that decides most coverage questions, compare the products themselves.

Route, prescriptions, what MassHealth paid and what all payers paid, for each GLP-1 product, 2026Q1
Product	Paid through	Prescriptions	Shareof this program	Program paidbefore rebates	All payers	Program per Rx
tirzepatideZepbound®	Both40,280 managed care, 11,845 direct	at least 52,125¹	51%	$53,633,551	$54,249,935	$1,029
tirzepatideMounjaro®	Both30,993 managed care, 10,235 direct	at least 41,228⁷	40%	$43,243,025	$43,753,578	$1,049
semaglutideWegovy®	Both2,069 managed care, 918 direct	at least 2,987¹³	3%	$3,073,262	$3,817,403	$1,029
semaglutideOzempic®	Both3,923 managed care, 1,473 direct	at least 5,396¹⁹	5%	$5,118,835	$5,312,245	$949
semaglutideRybelsus®	Both322 managed care, 148 direct	470²⁵	<1%	$449,022	$463,662	$955
liraglutideSaxenda®	Both	Withheld	n/a	Not published	Not published	Not published
liraglutideVictoza®	Both114 managed care, 42 direct	156³⁷	<1%	$102,950	$102,950	$660
liraglutideliraglutide (generic)	Both	at least 13⁴³	<1%	$7,469	$11,715	$575

MassHealth publishes claims on both routes: paid directly by the program, and paid through the managed-care plans it contracts with. The figures above combine the two, so which one your own card names decides who answers a question about your prescription.

Across the 21 quarters on file, prescriptions for the products published at both ends of the series were lower in 2026Q1 than in 2021Q1: 156 against 2,282. Products whose count was withheld at either end are left out of that comparison, because a floor against a number cannot establish a direction.

Against enrollment, that is 73.8 to 73.9 prescriptions per thousand people enrolled in MassHealth, on an average of 1,388,059 enrollees across the quarter. A raw count compares programs by how many people they cover; this is the figure that compares them by what they paid for.

2026Q1 covers January through March 2026, and it is the newest quarter CMS has published; that file was released on July 10, 2026. Every count here is a prescription filled rather than a person: one patient on a monthly product contributes several in a quarter, so nothing on this page says how many people take these products.

The file withheld 26 of the 168 product-quarters it holds a row for here, which is 15 percent. Each withheld cell records prescriptions that were paid for and a count that is not disclosed, so any total on this page that includes one is a floor rather than a sum.

Ozempic®, Rybelsus® and Victoza® carry a published count in every one of the 21 quarters, which is the closest this record comes to showing a product paid for routinely.

21 quarters, 2021Q1 to 2026Q1

One quarter cannot tell you whether MassHealth pays for a product routinely or barely at all, and a single withheld cell reads as an absence when it is not.

Show what MassHealth paid for each product, quarter by quarter

Prescriptions MassHealth paid for, by product and quarter, 2021Q1 to 2026Q1
Product	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
tirzepatideZepbound®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴No row	at least 148 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld³At least$135,217 paid	at least 192 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld³At least$139,459 paid	at least 758 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld³At least$559,670 paid	at least 10,776 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld³At least$10,535,993 paid	at least 42,125 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²At least$42,815,916 paid	at least 52,467 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²At least$53,146,878 paid	at least 55,889 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²At least$57,309,213 paid	at least 57,634 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²At least$59,636,826 paid	at least 52,125 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹At least$53,633,551 paid
tirzepatideMounjaro®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹¹No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter¹¹No row	withheld as a small cell paid prescriptions in the quarter (2022Q3)every reporting cell was withheld, so nothing is observable¹¹Withheld5 of 5 product codes withheld	at least 267 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹¹At least$213,030 paid	at least 768 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁰At least$686,262 paid	at least 2,528 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld¹⁰At least$2,452,468 paid	at least 2,584 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld¹⁰At least$2,615,480 paid	at least 3,423 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld¹⁰At least$3,433,815 paid	at least 4,399 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld⁹At least$4,424,130 paid	at least 4,777 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld⁹At least$4,858,796 paid	at least 7,483 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁹At least$7,683,370 paid	at least 8,500 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁹At least$8,520,897 paid	at least 8,726 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁸At least$8,608,907 paid	at least 9,112 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁸At least$8,928,122 paid	at least 14,455 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁸At least$14,533,855 paid	at least 28,981 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁸At least$29,611,536 paid	at least 41,228 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁷At least$43,243,025 paid
semaglutideWegovy®range 1,919 to 25,441	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹⁸No row	withheld as a small cell paid prescriptions in the quarter (2021Q3)every reporting cell was withheld, so nothing is observable¹⁸Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2021Q4)every reporting cell was withheld, so nothing is observable¹⁸Withheld5 of 5 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q1)every reporting cell was withheld, so nothing is observable¹⁷Withheld4 of 4 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q2)every reporting cell was withheld, so nothing is observable¹⁷Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q3)every reporting cell was withheld, so nothing is observable¹⁷Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q4)every reporting cell was withheld, so nothing is observable¹⁷Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q1)every reporting cell was withheld, so nothing is observable¹⁶Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q2)every reporting cell was withheld, so nothing is observable¹⁶Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q3)every reporting cell was withheld, so nothing is observable¹⁶Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q4)every reporting cell was withheld, so nothing is observable¹⁶Withheld2 of 2 product codes withheld	at least 1,748 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld¹⁵At least$2,168,188 paid	10,508 paid prescriptions in the quarter (2024Q2)¹⁵Count$13,503,904 paid	25,441 paid prescriptions in the quarter (2024Q3)¹⁵Count$32,932,014 paid	at least 27,621 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld¹⁵At least$35,238,852 paid	at least 3,169 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld¹⁴At least$3,442,995 paid	1,919 paid prescriptions in the quarter (2025Q2)¹⁴Count$1,848,671 paid	1,931 paid prescriptions in the quarter (2025Q3)¹⁴Count$1,926,643 paid	at least 2,148 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld¹⁴At least$2,150,477 paid	at least 2,987 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹³At least$3,073,262 paid
semaglutideOzempic®range 1,230 to 12,756	1,230 paid prescriptions in the quarter (2021Q1)²⁴Count$1,120,531 paid	1,338 paid prescriptions in the quarter (2021Q2)²⁴Count$1,254,851 paid	1,357 paid prescriptions in the quarter (2021Q3)²⁴Count$1,287,851 paid	at least 1,461 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld²⁴At least$1,394,953 paid	at least 1,533 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²³At least$1,554,135 paid	at least 1,990 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²³At least$2,074,897 paid	at least 2,195 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²³At least$2,198,617 paid	at least 2,365 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²³At least$2,134,790 paid	at least 3,271 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²²At least$2,992,198 paid	at least 6,636 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²²At least$6,054,571 paid	at least 5,804 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²²At least$5,480,593 paid	at least 5,062 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²²At least$4,755,062 paid	at least 6,870 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²¹At least$6,567,118 paid	at least 9,649 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²¹At least$9,298,389 paid	at least 13,455 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²¹At least$13,027,945 paid	at least 12,869 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²¹At least$12,007,480 paid	at least 12,031 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁰At least$11,232,894 paid	12,756 paid prescriptions in the quarter (2025Q2)²⁰Count$11,944,174 paid	at least 10,176 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁰At least$9,573,952 paid	6,498 paid prescriptions in the quarter (2025Q4)²⁰Count$6,105,480 paid	at least 5,396 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹⁹At least$5,118,835 paid
semaglutideRybelsus®range 137 to 829, down 26 on the quarter before	at least 65 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld³⁰At least$54,672 paid	at least 103 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld³⁰At least$86,408 paid	137 paid prescriptions in the quarter (2021Q3)³⁰Count$134,219 paid	at least 131 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld³⁰At least$122,149 paid	at least 164 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²⁹At least$175,787 paid	at least 269 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²⁹At least$288,884 paid	at least 315 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²⁹At least$331,164 paid	at least 396 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²⁹At least$359,393 paid	at least 480 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²⁸At least$449,693 paid	at least 627 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²⁸At least$615,544 paid	at least 533 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²⁸At least$547,922 paid	at least 543 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²⁸At least$549,233 paid	at least 643 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²⁷At least$666,579 paid	at least 718 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²⁷At least$737,077 paid	at least 821 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²⁷At least$854,175 paid	at least 849 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²⁷At least$818,193 paid	829 paid prescriptions in the quarter (2025Q1)²⁶Count$773,806 paid	761 paid prescriptions in the quarter (2025Q2)²⁶Count$702,801 paid	633 paid prescriptions in the quarter (2025Q3)²⁶Count$592,638 paid	496 paid prescriptions in the quarter (2025Q4)²⁶Count$468,902 paid	470 paid prescriptions in the quarter (2026Q1)²⁵Count$449,022 paid
liraglutideSaxenda®range 36 to 372	withheld as a small cell paid prescriptions in the quarter (2021Q1)every reporting cell was withheld, so nothing is observable³⁶Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2021Q2)every reporting cell was withheld, so nothing is observable³⁶Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter³⁶No row	withheld as a small cell paid prescriptions in the quarter (2021Q4)every reporting cell was withheld, so nothing is observable³⁶Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q1)every reporting cell was withheld, so nothing is observable³⁵Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q2)every reporting cell was withheld, so nothing is observable³⁵Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q3)every reporting cell was withheld, so nothing is observable³⁵Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q4)every reporting cell was withheld, so nothing is observable³⁵Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q1)every reporting cell was withheld, so nothing is observable³⁴Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q2)every reporting cell was withheld, so nothing is observable³⁴Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q3)every reporting cell was withheld, so nothing is observable³⁴Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q4)every reporting cell was withheld, so nothing is observable³⁴Withheld1 of 1 product codes withheld	at least 31 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld³³At least$40,491 paid	213 paid prescriptions in the quarter (2024Q2)³³Count$261,135 paid	372 paid prescriptions in the quarter (2024Q3)³³Count$455,441 paid	285 paid prescriptions in the quarter (2024Q4)³³Count$344,537 paid	38 paid prescriptions in the quarter (2025Q1)³²Count$34,625 paid	41 paid prescriptions in the quarter (2025Q2)³²Count$34,833 paid	36 paid prescriptions in the quarter (2025Q3)³²Count$36,492 paid	withheld as a small cell paid prescriptions in the quarter (2025Q4)every reporting cell was withheld, so nothing is observable³²Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2026Q1)every reporting cell was withheld, so nothing is observable³¹Withheld1 of 1 product codes withheld
liraglutideVictoza®range 131 to 2,700, down 41 on the quarter before	2,282 paid prescriptions in the quarter (2021Q1)⁴²Count$2,318,992 paid	2,384 paid prescriptions in the quarter (2021Q2)⁴²Count$2,540,650 paid	2,145 paid prescriptions in the quarter (2021Q3)⁴²Count$2,285,029 paid	1,978 paid prescriptions in the quarter (2021Q4)⁴²Count$2,123,177 paid	1,888 paid prescriptions in the quarter (2022Q1)⁴¹Count$2,031,794 paid	1,980 paid prescriptions in the quarter (2022Q2)⁴¹Count$2,154,054 paid	1,974 paid prescriptions in the quarter (2022Q3)⁴¹Count$2,129,918 paid	2,310 paid prescriptions in the quarter (2022Q4)⁴¹Count$2,195,726 paid	2,676 paid prescriptions in the quarter (2023Q1)⁴⁰Count$2,639,872 paid	2,700 paid prescriptions in the quarter (2023Q2)⁴⁰Count$2,745,799 paid	2,199 paid prescriptions in the quarter (2023Q3)⁴⁰Count$2,235,037 paid	2,016 paid prescriptions in the quarter (2023Q4)⁴⁰Count$2,080,204 paid	1,797 paid prescriptions in the quarter (2024Q1)³⁹Count$1,315,245 paid	1,155 paid prescriptions in the quarter (2024Q2)³⁹Count$814,503 paid	904 paid prescriptions in the quarter (2024Q3)³⁹Count$635,075 paid	706 paid prescriptions in the quarter (2024Q4)³⁹Count$482,425 paid	392 paid prescriptions in the quarter (2025Q1)³⁸Count$238,416 paid	169 paid prescriptions in the quarter (2025Q2)³⁸Count$104,353 paid	131 paid prescriptions in the quarter (2025Q3)³⁸Count$77,128 paid	197 paid prescriptions in the quarter (2025Q4)³⁸Count$119,215 paid	156 paid prescriptions in the quarter (2026Q1)³⁷Count$102,950 paid
liraglutideliraglutide (generic)	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter⁴⁵No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter⁴⁵No row	withheld as a small cell paid prescriptions in the quarter (2024Q3)every reporting cell was withheld, so nothing is observable⁴⁵Withheld4 of 4 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q4)every reporting cell was withheld, so nothing is observable⁴⁵Withheld4 of 4 product codes withheld	at least 13 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁴⁴At least$4,090 paid	at least 55 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁴⁴At least$27,618 paid	at least 41 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁴⁴At least$21,456 paid	at least 12 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁴⁴At least$5,063 paid	at least 13 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁴³At least$7,469 paid

What this page cannot tell you

Whether MassHealth covers these products is decided by a document this site has not read yet: its preferred drug list and the prior-authorization criteria behind it. Until that is read and quoted, the payment history above is all this page asserts. Start from the notice or the drug list the program sent you, and check which document governs your plan first, because no state rule reaches a self-funded employer plan at all.

Open Massachusetts in the coverage explorer to see all 21 quarters of trend per product and switch jurisdictions without leaving the table.

Compare another jurisdiction from the national comparison.

Documents this page reads

48 documents, cited by number above. Each opens to its section, its effective date, and the quote the fact came from.

SDUD 2026, Zepbound, MA
State Drug Utilization Data 2026, Datastore query result, product_name like ZEPBOUND%, state MA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MA", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "ZEPBOUND 1", "suppression_used": "false", "number_of_prescriptions": "8549"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Zepbound, MA
State Drug Utilization Data 2025, Datastore query result, product_name like ZEPBOUND%, state MA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "ZEPBOUND 5", "suppression_used": "false", "number_of_prescriptions": "11363"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Zepbound, MA
State Drug Utilization Data 2024, Datastore query result, product_name like ZEPBOUND%, state MA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND 2", "suppression_used": "false", "number_of_prescriptions": "4245"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Zepbound, MA
State Drug Utilization Data 2023, Datastore query result, product_name like ZEPBOUND%, state MA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "product_name": "product_name like ZEPBOUND%, state MA, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Zepbound, MA
State Drug Utilization Data 2022, Datastore query result, product_name like ZEPBOUND%, state MA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "product_name": "product_name like ZEPBOUND%, state MA, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Zepbound, MA
State Drug Utilization Data 2021, Datastore query result, product_name like ZEPBOUND%, state MA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "product_name": "product_name like ZEPBOUND%, state MA, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Mounjaro, MA
State Drug Utilization Data 2026, Datastore query result, product_name like MOUNJARO%, state MA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MA", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "7557"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Mounjaro, MA
State Drug Utilization Data 2025, Datastore query result, product_name like MOUNJARO%, state MA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "5781"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Mounjaro, MA
State Drug Utilization Data 2024, Datastore query result, product_name like MOUNJARO%, state MA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "1683"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Mounjaro, MA
State Drug Utilization Data 2023, Datastore query result, product_name like MOUNJARO%, state MA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "759"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Mounjaro, MA
State Drug Utilization Data 2022, Datastore query result, product_name like MOUNJARO%, state MA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "year": "2022", "quarter": "4", "utilization_type": "FFSU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "96"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Mounjaro, MA
State Drug Utilization Data 2021, Datastore query result, product_name like MOUNJARO%, state MA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "product_name": "product_name like MOUNJARO%, state MA, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Wegovy, MA
State Drug Utilization Data 2026, Datastore query result, product_name like WEGOVY%, state MA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MA", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "687"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Wegovy, MA
State Drug Utilization Data 2025, Datastore query result, product_name like WEGOVY%, state MA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "year": "2025", "quarter": "1", "utilization_type": "FFSU", "product_name": "WEGOVY 2.4", "suppression_used": "false", "number_of_prescriptions": "383"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Wegovy, MA
State Drug Utilization Data 2024, Datastore query result, product_name like WEGOVY%, state MA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "year": "2024", "quarter": "3", "utilization_type": "MCOU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "5476"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Wegovy, MA
State Drug Utilization Data 2023, Datastore query result, product_name like WEGOVY%, state MA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 1.7", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Wegovy, MA
State Drug Utilization Data 2022, Datastore query result, product_name like WEGOVY%, state MA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 1.7", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Wegovy, MA
State Drug Utilization Data 2021, Datastore query result, product_name like WEGOVY%, state MA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 1 M", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Ozempic, MA
State Drug Utilization Data 2026, Datastore query result, product_name like OZEMPIC%, state MA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MA", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "OZEMPIC 2 ", "suppression_used": "false", "number_of_prescriptions": "1819"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Ozempic, MA
State Drug Utilization Data 2025, Datastore query result, product_name like OZEMPIC%, state MA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "year": "2025", "quarter": "2", "utilization_type": "MCOU", "product_name": "OZEMPIC 2 ", "suppression_used": "false", "number_of_prescriptions": "4129"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Ozempic, MA
State Drug Utilization Data 2024, Datastore query result, product_name like OZEMPIC%, state MA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "year": "2024", "quarter": "3", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "4000"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Ozempic, MA
State Drug Utilization Data 2023, Datastore query result, product_name like OZEMPIC%, state MA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "year": "2023", "quarter": "2", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "2793"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Ozempic, MA
State Drug Utilization Data 2022, Datastore query result, product_name like OZEMPIC%, state MA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 1 ", "suppression_used": "false", "number_of_prescriptions": "651"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Ozempic, MA
State Drug Utilization Data 2021, Datastore query result, product_name like OZEMPIC%, state MA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 1 ", "suppression_used": "false", "number_of_prescriptions": "446"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Rybelsus, MA
State Drug Utilization Data 2026, Datastore query result, product_name like RYBELSUS%, state MA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MA", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "151"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Rybelsus, MA
State Drug Utilization Data 2025, Datastore query result, product_name like RYBELSUS%, state MA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "296"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Rybelsus, MA
State Drug Utilization Data 2024, Datastore query result, product_name like RYBELSUS%, state MA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "260"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Rybelsus, MA
State Drug Utilization Data 2023, Datastore query result, product_name like RYBELSUS%, state MA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "year": "2023", "quarter": "2", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "188"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Rybelsus, MA
State Drug Utilization Data 2022, Datastore query result, product_name like RYBELSUS%, state MA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "83"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Rybelsus, MA
State Drug Utilization Data 2021, Datastore query result, product_name like RYBELSUS%, state MA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "year": "2021", "quarter": "2", "utilization_type": "FFSU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "40"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Saxenda, MA
State Drug Utilization Data 2026, Datastore query result, product_name like SAXENDA%, state MA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MA", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "SAXENDA 18", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Saxenda, MA
State Drug Utilization Data 2025, Datastore query result, product_name like SAXENDA%, state MA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "year": "2025", "quarter": "2", "utilization_type": "FFSU", "product_name": "SAXENDA 18", "suppression_used": "false", "number_of_prescriptions": "23"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Saxenda, MA
State Drug Utilization Data 2024, Datastore query result, product_name like SAXENDA%, state MA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "year": "2024", "quarter": "3", "utilization_type": "MCOU", "product_name": "SAXENDA 18", "suppression_used": "false", "number_of_prescriptions": "289"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Saxenda, MA
State Drug Utilization Data 2023, Datastore query result, product_name like SAXENDA%, state MA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA 18", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Saxenda, MA
State Drug Utilization Data 2022, Datastore query result, product_name like SAXENDA%, state MA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA 18", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Saxenda, MA
State Drug Utilization Data 2021, Datastore query result, product_name like SAXENDA%, state MA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA 18", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Victoza, MA
State Drug Utilization Data 2026, Datastore query result, product_name like VICTOZA%, state MA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MA", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 2-", "suppression_used": "false", "number_of_prescriptions": "65"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Victoza, MA
State Drug Utilization Data 2025, Datastore query result, product_name like VICTOZA%, state MA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 2-", "suppression_used": "false", "number_of_prescriptions": "171"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Victoza, MA
State Drug Utilization Data 2024, Datastore query result, product_name like VICTOZA%, state MA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "year": "2024", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "886"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Victoza, MA
State Drug Utilization Data 2023, Datastore query result, product_name like VICTOZA%, state MA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "year": "2023", "quarter": "2", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "1242"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Victoza, MA
State Drug Utilization Data 2022, Datastore query result, product_name like VICTOZA%, state MA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "year": "2022", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "894"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Victoza, MA
State Drug Utilization Data 2021, Datastore query result, product_name like VICTOZA%, state MA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "year": "2021", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "1091"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Liraglutid, MA
State Drug Utilization Data 2026, Datastore query result, product_name like LIRAGLUTID%, state MA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MA", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "13"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Liraglutid, MA
State Drug Utilization Data 2025, Datastore query result, product_name like LIRAGLUTID%, state MA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "year": "2025", "quarter": "3", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "25"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Liraglutid, MA
State Drug Utilization Data 2024, Datastore query result, product_name like LIRAGLUTID%, state MA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Liraglutid, MA
State Drug Utilization Data 2023, Datastore query result, product_name like LIRAGLUTID%, state MA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "product_name": "product_name like LIRAGLUTID%, state MA, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Liraglutid, MA
State Drug Utilization Data 2022, Datastore query result, product_name like LIRAGLUTID%, state MA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "product_name": "product_name like LIRAGLUTID%, state MA, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Liraglutid, MA
State Drug Utilization Data 2021, Datastore query result, product_name like LIRAGLUTID%, state MA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MA", "product_name": "product_name like LIRAGLUTID%, state MA, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026

How the quoted row is presented, for 41 of these documents

One row of the API response for the query in url, with the fields that do not bear on this fact omitted and the rest left exactly as the API returns them, including the trailing spaces the ten-character product_name field pads with. Open the url to re-read the whole result set and re-sum it.

How the quoted row is presented, for 7 of these documents

The query in url returns an empty result set, which is the evidence. An absence cannot be quoted, so the record states the query and its count instead.

Common questions

Does a paid prescription mean MassHealth covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.